HB1796

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

Introduced·12/17/25
Text Text

Allows use of psilocybin in approved clinical settings to treat qualified medical conditions.

New Hampshire HB1796 establishes a regulated system for the medical use of psilocybin to treat conditions like major depression, PTSD, and substance use disorders. The bill creates a medical use of psilocybin program within the Department of Health and Human Services. It outlines licensing requirements for psilocybin production establishments, independent testing laboratories, and qualified medical psilocybin providers. The bill also establishes a psilocybin licensing board to oversee the program.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
In committee
Next
Committee decision

Sponsors

DD
2
7
RRRRRRR
Democratic CaucusRepublican Caucus

Calendar

Jan 28

2:30 PM

Health, Human Services and Elderly Affairs Executive Session

Jan 14

2:00 PM

Health, Human Services and Elderly Affairs Public Hearing

History

Feb 3

House

Majority Committee Report: Inexpedient to Legislate 01/28/2026 (Vote 11-7; Regular Calendar) House Calendar 10 P. 91

Feb 3

House

Minority Committee Report: Ought to Pass

Jan 21

House

Executive Session: 01/28/2026 02:30 pm GP 158